Precision Biosciences Inc SEC filings DTIL
Precision Biosciences Inc has 606 filings in SEC EDGAR's recent list, going back to Mar 15, 2006. Its latest annual report, Form ARS, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (other events). The company's fiscal year ends on May 21.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 6, 2026 | Nov 5, 2026 |
| 424B5 | Prospectus supplement | Nov 6, 2026 | — |
| 144 | Notice of proposed sale | Nov 5, 2026 | — |
| FWP | Free writing prospectus | Nov 5, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 5, 2026 | Nov 5, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 3, 2026 | — |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 27, 2026 | — |
| 4 | Insider transaction | Sep 30, 2026 | Sep 28, 2026 |
| 4 | Insider transaction | Sep 29, 2026 | Sep 25, 2026 |
| 4 | Insider transaction | Sep 29, 2026 | Sep 25, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 24, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 24, 2026 | Aug 24, 2026 |
| S-8 | Employee stock plan registration | Aug 7, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 3 | Initial insider ownership | Aug 3, 2026 | Aug 1, 2026 |
| 3 | Initial insider ownership | Aug 3, 2026 | Aug 1, 2026 |
| 3 | Initial insider ownership | Aug 3, 2026 | Aug 1, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 29, 2026 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 27, 2026 | Jul 23, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 20, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 1, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 16, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 27, 2026 | May 27, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
May 26, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 15, 2026 | — |
| ARS | Annual report to shareholders | Apr 8, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 8, 2026 | — |
| DEF 14A | Proxy statement | Apr 8, 2026 | May 21, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 27, 2026 | May 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 17, 2026 | Mar 17, 2026 |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 144 | Notice of proposed sale | Feb 18, 2026 | — |
| 144 | Notice of proposed sale | Feb 18, 2026 | — |
| 144 | Notice of proposed sale | Feb 18, 2026 | — |
| 144 | Notice of proposed sale | Feb 18, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 11, 2026 | Feb 11, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 10, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 27, 2026 | — |
| 4 | Insider transaction | Jan 22, 2026 | Jan 20, 2026 |
| 4 | Insider transaction | Jan 22, 2026 | Jan 20, 2026 |
| 4 | Insider transaction | Jan 22, 2026 | Jan 20, 2026 |
| 4 | Insider transaction | Jan 22, 2026 | Jan 20, 2026 |
| 144 | Notice of proposed sale | Jan 22, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 22, 2026 | — |
| 144 | Notice of proposed sale | Jan 21, 2026 | — |
| 144 | Notice of proposed sale | Jan 21, 2026 | — |
| 144 | Notice of proposed sale | Jan 21, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 13, 2026 | Jan 12, 2026 |
| EFFECT | Filing | Jan 7, 2026 | — |
| CORRESP | Letter to the SEC | Jan 5, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 2, 2026 | — |
| S-3 | Shelf registration | Dec 30, 2025 | — |
| S-8 | Employee stock plan registration | Dec 30, 2025 | — |
| 4 | Insider transaction | Dec 17, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 17, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 17, 2025 | Dec 15, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 12, 2025 | Nov 10, 2025 |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| FWP | Free writing prospectus | Nov 10, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 10, 2025 | Nov 10, 2025 |
| 4 | Insider transaction | Nov 4, 2025 | Nov 2, 2025 |
| 4 | Insider transaction | Nov 4, 2025 | Nov 2, 2025 |
| 4 | Insider transaction | Nov 4, 2025 | Nov 2, 2025 |
| 144 | Notice of proposed sale | Nov 3, 2025 | — |
| 144 | Notice of proposed sale | Nov 3, 2025 | — |
| 144 | Notice of proposed sale | Nov 3, 2025 | — |
| 10-Q | Quarterly report | Nov 3, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2025 | Nov 3, 2025 |
| 4 | Insider transaction | Sep 30, 2025 | Sep 26, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 2, 2025 | Aug 26, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 6, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 6, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 6, 2025 | Aug 6, 2025 |
| 4 | Insider transaction | Jul 8, 2025 | Jul 3, 2025 |
| 144 | Notice of proposed sale | Jul 3, 2025 | — |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | May 27, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | May 27, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | May 27, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | May 27, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | May 27, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 2, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2025 | May 28, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2025 | May 15, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 14, 2025 | May 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 25, 2025 | — |
| ARS | Annual report to shareholders | Apr 15, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 15, 2025 | — |
| DEF 14A | Proxy statement | Apr 15, 2025 | May 28, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 4, 2025 | May 28, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 27, 2025 | Mar 25, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 26, 2025 | — |
| 424B5 | Prospectus supplement | Mar 26, 2025 | — |
| 10-K | Annual report | Mar 26, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 25, 2025 | Mar 21, 2025 |
| 144 | Notice of proposed sale | Mar 24, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 18, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Mar 7, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 144 | Notice of proposed sale | Mar 5, 2025 | — |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jan 29, 2025 | Jan 23, 2025 |
| 144 | Notice of proposed sale | Jan 24, 2025 | — |
| 4 | Insider transaction | Jan 22, 2025 | Jan 20, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 20, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 20, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 20, 2025 |
| 144 | Notice of proposed sale | Jan 22, 2025 | — |
| 144 | Notice of proposed sale | Jan 22, 2025 | — |
| 144 | Notice of proposed sale | Jan 21, 2025 | — |
| 8-K |
Current report
Results of operations, Other events
|
Jan 8, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 30, 2024 |
| 4 | Insider transaction | Dec 31, 2024 | Dec 27, 2024 |
| 4 | Insider transaction | Dec 31, 2024 | Dec 27, 2024 |
| 4 | Insider transaction | Dec 30, 2024 | Dec 26, 2024 |
| 4 | Insider transaction | Nov 21, 2024 | Nov 21, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| 4 | Insider transaction | Nov 5, 2024 | Nov 2, 2024 |
| 4 | Insider transaction | Nov 5, 2024 | Nov 2, 2024 |
| 4 | Insider transaction | Nov 5, 2024 | Nov 2, 2024 |
| 144 | Notice of proposed sale | Nov 4, 2024 | — |
| 144 | Notice of proposed sale | Nov 4, 2024 | — |
| 10-Q | Quarterly report | Nov 4, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Oct 24, 2024 | Oct 24, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 12, 2024 | Sep 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 3, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Aug 23, 2024 | Aug 22, 2024 |
| 4 | Insider transaction | Aug 23, 2024 | Aug 22, 2024 |
| 4 | Insider transaction | Aug 23, 2024 | Aug 22, 2024 |
| 4 | Insider transaction | Aug 23, 2024 | Aug 22, 2024 |
| 10-Q | Quarterly report | Aug 1, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2024 | Aug 1, 2024 |
| S-8 | Employee stock plan registration | Jul 1, 2024 | — |
| 4 | Insider transaction | Jun 11, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 11, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 11, 2024 | Jun 7, 2024 |
| 144 | Notice of proposed sale | Jun 10, 2024 | — |
| 144 | Notice of proposed sale | Jun 10, 2024 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 10, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- DTIL (Nasdaq)
- Fiscal year ends
- May 21
- Incorporated in
- DE
- Headquarters
- Durham, NC
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1357874
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.